Sains Malaysiana 40(5)(2011): 467–473

Association Between Dialysis Dose and Biochemical Blood Parameters

(Hubungan antara Dos Dialisis dan Parameter Biokimia)

Nur Zakiah Mohd. Saat^1, *, Sazlina Kamaralzaman²  Norshafarina Shaari¹ & Farida Zuraina Mohd. Yusoff³

¹Department of Biomedical Science, Faculty of Allied Health Science

Universiti Kebangsaan Malaysia, 50300 Kuala Lumpur, Malaysia

²Programme of Ocupational Theraphy, Faculty of Allied Health Science

Universiti Kebangsaan Malaysia, 50300 Kuala Lumpur, Malaysia

³Faculty of Applied Sciences, Universiti Teknologi MARA

40450 Shah Alam, Selangor, Malaysia

Diserahkan: 12 Mac 2010 / Diterima: 15 Julai 2010

ABTRACT

The end stage renal disease (ESRD) patients requires hemodialysis to survive. Efficacy of the treatment is determined by evaluation of minimal dialysis dose (Kt/V) which is 1.2. A cross sectional study was conducted among patients that undergo hemodialysis in a dialysis centre in Kuala Lumpur, Malaysia. The objectives of the study were to determine the association between dialysis dose and demographic factors and assessed the association between biochemical blood parameter and the demographic factors. The biochemical blood parameters were serum albumin, creatinine, cholesterol and hemoglobin. Result showed that all Indians and 54% of Chinese patients achieved the required dialysis dose. However only 29% of Malay patients attained the effective dialysis dose. More women patients accomplished the dialysis dose of at least 1.2 compared to men patients with odd ratio of 11.24. All the biochemical blood parameters were independent of the demographic factors. However, the cholesterol level was associated significantly with gender (p<0.05). In conclusion, the study found the biochemical blood parameter and dialysis dose were not influenced by the demographic factors.

Keywords: Biochemical blood parameters; dialysis dose; end stage renal disease; hemodialysis

ABSTRAK

Pesakit yang mengalami kegagalan renal peringkat lewat (ESRD) perlu menjalani rawatan hemodialisis untuk meneruskan kehidupan. Kerbekesanan rawatan ditentukan berdasarkan kepada dos dialisis (Kt/V) iaitu 1.2. Suatu kajian keratan rentas telah dijalankan ke atas pesakit yang menerima rawatan hemodialisis di pusat dialisis di Kuala Lumpur, Malaysia. Objektif kajian ini adalah untuk menentukan hubungan antara dos dialisis dengan faktor demografi. Kedua, kajian ini juga ingin menentukan hubungan antara parameter biokimia dan faktor demografi. Parameter biokimia adalah serum albumin, kreatinin, kolesterol dan hemoglobin. Hasil kajian menunjukkan bahawa kesemua pesakit berbangsa India dan 54% pesakit berbangsa Cina mencapai dos dialisis yang diperlukan. Walau bagaimanapun, hanya 29% pesakit berbangsa Melayu mencapai dos yang efektif. Lebih ramai pesakit wanita yang mencapai dos dialisis sekurang-kurangnya 1.2 berbanding dengan pesakit lelaki dengan nisbah odds 11.24. Kesemua parameter biokimia adalah tidak bersandar dengan faktor demografi. Walau bagaimanapun aras kolesterol mempunyai hubungan yang signifikan dengan faktor jantina (p<0.05). Kesimpulannya, kajian ini menunjukkan bahawa parameter biokimia dan dos dialisis tidak mempunyai perkaitan dengan faktor demografi.

Kata kunci: Dos dialisis; hemodialisis; kegagalan renal peringkat lewat; parameter biokimia

RUJUKAN

Abu Bakar, S. & Zaki, M. 1986. Home hemodialysis in Malaysia. Med J Malaysia 41(4): 320-326.

Avram, A., Bonomini L, Sreedhara, R. & Mittman, N. 1996. Predictive value of nutritional markers (albumin, creatinine, cholesterol, and hematocrit) for patients on dialysis for up to 30 years. Am. J. Kidney Dis. 28(6): 910-917.

Besarab, A. 1995. Hematologic aspects of uremia. In Nissenson, A.R., Fine, R.N. & Gentile, D.E. (Ed.). Clinical dialysis pp 618-651. 3rd Ed . USA: Prentice Hall International, Inc.

Block, G., Klassen, P.S., Lazarus, M., Ofsthun, N., Lowrie, E.G. & Chertow, G.M. 2004. Mineral Metabolism, Mortality and Morbidity in Maintenance Hemodialysis. J. Am. Soc Nephrol 15: 2208-2218.

Chan, M.K. 1995. Lipoprotein Metabolism and Dyslipidemia in Dialysis Patients In. Clinical Dialysis, edited by Nissenson, A.R., Fine, R.N. & Gentile, D.E. 3rd Ed. USA: Prentice Hall International, Inc.

Degoulet, P., Legrain, M., Reach, I., Aime, F., Devries, C., Rojas, P. & Jacobs, C. 1982. Mortality risk factors in patients treated by chronic hemodialysis. Nephron 31: 103-110.

Depner, T.A. 1998. Benefits of more frequent dialysis: lower TAC at the same Kt/V. Nephrol Dial Transplant 13(6): 20-24.

Don, R.D. & Kaysen G. 2004. Poor Nutritional Status and Inflammation: Serum Albumin: Relationship to Inflammation and Nutrition. Seminars in Dialysis 17(6): 432-437.

Drüeke, T.B., Locatelli, F., Clyne, N., Eckardt, K., Macdougall, I.C., Tsakiris, D., Burger, H. & Scherhag, A. 2006. Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia. N. Engl. J. Med. 355(20): 2071-2084.

Fenton, S.A., Schaubel, D.E., Desmeules, M., Morrison, H.I., Mao, Y., Copleston, P., Jeffery, J.R. & Kjellstrand, C.M. 1997. Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am. J. Kidney Dis. 30: 334-342.

Fisell, R.B., Bragg-Gresham,J.L., Woods, J.D., Jadoul, M., Gillespie, B., Hedderwick, S.A., Rayner, H.C., Greenwood, R.N., Akiba, T. & Young E.W. 2004. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: The DOPPS. Kidney Int. 65: 2335-2342.

Foley, R.N., Parfrey, P.S., Morgan, J., Barré, P.E., Campbell, P., Cartier, P., Coyle, D., Fine, A., Handa, P., Kingma, I., Lau, C.Y., Levin, A., Mendelssohn, D., Muirhead, N., Murphy, B., Plante, R.K., Posen, G. & Wells, G.A. 2000. Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney Int. 58: 1325-1335.

Frankenfield, D.L., Rocco,M.V., Frederick, P.R., Pugh, J., McClellan, W.M. & Owen W.F. 1999. Racial/Ethnic Analysis of Selected Intermediate Outcomes forHemodialysis Patients: Results From the 1997 ESRD Core Indicators Project. Am. J. Kidney Dis. 34(4): 721-730.

Gotch F.A. & Sargent J.A. 1985. A mechanistic analysis of the National Cooperative Dialysis Study. Kidney Int 28: 526-534.

Held, P.J., Pauly, M.V. & Diamond, L. 1987. Survival analysis of patients undergoing dialysis. J. Am. Med. Assoc 257(5): 645-650.

Held, P.J., Port, F.K., Wolfe, R.A., Stannard, D.C., Daugirdaus, J.T., Bloembergen, W.E., Greer, J.W. & Harris, R.M. 1996. The dose of hemodialysis and patient mortality. Kidney Int. 50: 550-556.

Horowitz, M., Need, A.G., Philcox, J.C. & Nordin, B.E. 1984. Effect of calcium supplementation on urinary hydroxyproline in osteoporotic postmenopausal women. Am. J. Clin. Nutr. 39: 857-859.

Kalantar-Zadeh, K., Supasyndh, O., Lehn, R.S., McAllister, C.J., Kopple, J.D. 2003. Normalized protein nitrogen appearance is correlated with hospitalization and mortality in hemodialysis patients with Kt/V greater than 1.20. J Ren. Nutr. 13(1): 15-25.

Liu, Y., Coresh, J., Eustace, J.A., Longenecker, C., Jaar, B., Fink, N.E., Tracy, R.P., Powe, N.R. & Klag, M.G. 2004. Association Between Cholesterol Level and Mortality I Dialysis Patients Role of Inflammation and Malnutrition. J. Am. Med. Assoc. 291(4): 451-459.

Locatelli, F., Vecchio, L.D. & Manzoni, C. 1998. Morbidity and mortality on maintenance hemodialysis. Nephron. 80(4): 380-395.

Lowrie, E.G. & Lew, N.L. 1990. Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am. J. Kidney Dis. 15(5): 458-482.

Mattana J., Patel A., Wagner J.D., Maesaka J.K. & Singhal P.C. 1995. Effect of time of day of dialysis shift on serum biochemical parameters in patients on chronic hemodialysis. Am. J. Nephrol. 15: 208-216.

Mulder, W. & Hillen, H.F.P. 2001. Renal function and renal disease in the elderly: Part II Eur. J. Int. Med. 12(4): 327-333.

Ofsthun, N., Labrecque, J., Lacson, E., Keen, M. & Lazarus, J.M. 2003. The effects of higher hemoglobin levels on mortality and hospitalization in hemodialysis patients. Kidney Int. 63(5): 1908-14.

Owen, W.F., Chertow, G.M., Lazarus, J.M. & Lowrie, E.G. 1998. Blacks receive lower doses of hemodialysis than whites but their survival rates are better than those of whites. J. Am. Med. Assoc. 280(20): 1764-1768.

Owen, W.F., Lew, N.L., Liu, Y., Lowrie, E.G. & Lazarus, J.M. 1993. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. New Engl. J. Med. 329: 1001-1006.

Skinner, S. 1996. Understanding Clinical Investigation. London: Baillliere Tindall

Spicer, S.T., Quinn, D., Nyi, N.N.N., Nankivell, B.J., Hayes, J.M. & Savdie, E. 1999. Acute Renal Impairment after Immersion and Near-Drowning. J Am. Soc. Nephrol. 10: 382-386.

Tattersal, J.E., DeTakats, D., Chamney, Greenwood, R.N. & Farrington, K. 1996. The post-hemodialysis rebound: Predicting and quantifying its effect on Kt/V. Kidney Int. 50: 2094-2102.

*Pengarang untuk surat-menyurat; email: nurza@medic.ukm.my